Industry commentators have welcomed Chancellor Philip Hammond's plans to support the growth of early-stage UK companies, as announced in last week's Budget, but some are sceptical about whether the changes could help raise significantly more capital through tax-efficient vehicles like EIS and VCTs.
The Chancellor launched the Patient Capital Review late last year in an attempt to overcome the barriers faced by young companies in the UK hoping to grow further. Chaired by Sir Damon Buffini, the...
Joined with 21 Partners
Consequences could be more severe than in stress tests
Move to variable operating expenses
Set to happen on 4 April